Pioneering Medicines
Flagship Pioneering Announces Two New Agreements with Ampersand Biomedicines and Montai Therapeutics Under its Strategic Partnership with Pfizer
Flagship Pioneering and Quotient Therapeutics Announce Agreement to Identify Potential Novel Targets for the Treatment of Cardiovascular and Renal Diseases under Strategic Partnership with Pfizer
Flagship Pioneering and ProFound Therapeutics Announce Agreement to Identify Novel First-in-Class Therapeutics for the Treatment of Obesity under Strategic Partnership with Pfizer
Flagship Pioneering and Metaphore Biotechnologies Announce Research Collaboration with Novo Nordisk to Develop Next-Generation Therapeutics for Obesity Management
Novo Nordisk Enters into Research Collaborations with Omega Therapeutics and Cellarity on Novel Treatment Approaches for Cardiometabolic Diseases
Flagship Pioneering and Pfizer Partner to Accelerate Development of Innovative Medicines Targeting Unmet Needs
Novo Nordisk and Flagship Pioneering announce a strategic collaboration to create a portfolio of transformational medicines
Vaithianathan "Palani" Palaniappan Joins to Lead Strategy and Implementation of Chemistry, Manufacturing and Controls (CMC)
Pioneering Medicines, an initiative of Flagship Pioneering, Establishes First-of-its-Kind Partnership with Cystic Fibrosis Foundation to Develop Breakthrough Treatments for CF
Luisa Salter-Cid to Pioneer Portfolio of Groundbreaking Medicines Sourced from the Scientific Platforms Within Flagship's Ecosystem of Companies
Dr. Luciano Rossetti to Provide Expert Advice and Direction on Flagship's Clinical Portfolio
Flagship's In-house Drug Development Unit will Discover and Develop New Medicines Built from Flagship's Innovative Platforms
Flagship Pioneering Strengthens Leadership With Appointment of Paul Biondi as Executive Partner to Lead New Drug Development Initiative